257 related articles for article (PubMed ID: 29526119)
1. Methylation levels of the TNFA gene are different between Graves' and Hashimoto's diseases and influenced by the TNFA polymorphism.
Morita E; Watanabe M; Inoue N; Hashimoto H; Haga E; Hidaka Y; Iwatani Y
Autoimmunity; 2018 May; 51(3):118-125. PubMed ID: 29526119
[TBL] [Abstract][Full Text] [Related]
2. Involvement of functional polymorphisms in the TNFA gene in the pathogenesis of autoimmune thyroid diseases and production of anti-thyrotropin receptor antibody.
Inoue N; Watanabe M; Nanba T; Wada M; Akamizu T; Iwatani Y
Clin Exp Immunol; 2009 May; 156(2):199-204. PubMed ID: 19250279
[TBL] [Abstract][Full Text] [Related]
3. Association of
Hirai N; Watanabe M; Inoue N; Kinoshita R; Ohtani H; Hidaka Y; Iwatani Y
Autoimmunity; 2019; 52(7-8):251-255. PubMed ID: 31552761
[TBL] [Abstract][Full Text] [Related]
4. Association of IFNG gene methylation in peripheral blood cells with the development and prognosis of autoimmune thyroid diseases.
Hashimoto H; Watanabe M; Inoue N; Hirai N; Haga E; Kinoshita R; Hidaka Y; Iwatani Y
Cytokine; 2019 Nov; 123():154770. PubMed ID: 31279175
[TBL] [Abstract][Full Text] [Related]
5. The polymorphisms in the thyroid peroxidase gene were associated with the development of autoimmune thyroid disease and the serum levels of anti-thyroid peroxidase antibody.
Tomari S; Watanabe M; Inoue N; Mizuma T; Yamanaka C; Hidaka Y; Iwatani Y
Endocr J; 2017 Oct; 64(10):1025-1032. PubMed ID: 28845025
[TBL] [Abstract][Full Text] [Related]
6. Association of the polymorphisms in the gene encoding thyroglobulin with the development and prognosis of autoimmune thyroid disease.
Mizuma T; Watanabe M; Inoue N; Arakawa Y; Tomari S; Hidaka Y; Iwatani Y
Autoimmunity; 2017 Sep; 50(6):386-392. PubMed ID: 28675712
[TBL] [Abstract][Full Text] [Related]
7. Methylation levels of the IL10 gene in peripheral blood are related to the intractability of Graves' disease.
Kinoshita R; Inoue N; Iwatani Y; Noguchi Y; Hidaka Y; Watanabe M
Clin Immunol; 2024 Jun; 263():110196. PubMed ID: 38570004
[TBL] [Abstract][Full Text] [Related]
8. TSHR Gene Polymorphisms in the Enhancer Regions Are Most Strongly Associated with the Development of Graves' Disease, Especially Intractable Disease, and of Hashimoto's Disease.
Fujii A; Inoue N; Watanabe M; Kawakami C; Hidaka Y; Hayashizaki Y; Iwatani Y
Thyroid; 2017 Jan; 27(1):111-119. PubMed ID: 27762730
[TBL] [Abstract][Full Text] [Related]
9. DICER and DROSHA gene expression and polymorphisms in autoimmune thyroid diseases.
Saeki M; Watanabe M; Inoue N; Tokiyoshi E; Takuse Y; Arakawa Y; Hidaka Y; Iwatani Y
Autoimmunity; 2016 Dec; 49(8):514-522. PubMed ID: 27808570
[TBL] [Abstract][Full Text] [Related]
10. Gene polymorphisms of VEGF and VEGFR2 are associated with the severity of Hashimoto's disease and the intractability of Graves' disease, respectively.
Okamoto M; Watanabe M; Inoue N; Ogawa K; Hidaka Y; Iwatani Y
Endocr J; 2020 May; 67(5):545-559. PubMed ID: 32074519
[TBL] [Abstract][Full Text] [Related]
11. The MAGI2 gene polymorphism rs2160322 is associated with Graves' disease but not with Hashimoto's thyroiditis.
Jia X; Zhai T; Wang B; Zhang J; Zhang F
J Endocrinol Invest; 2019 Jul; 42(7):843-850. PubMed ID: 30535759
[TBL] [Abstract][Full Text] [Related]
12. Functional Polymorphisms of the Type 1 and Type 2 Iodothyronine Deiodinase Genes in Autoimmune Thyroid Diseases.
Inoue N; Watanabe M; Katsumata Y; Ishido N; Hidaka Y; Iwatani Y
Immunol Invest; 2018 Jul; 47(5):534-542. PubMed ID: 29648895
[TBL] [Abstract][Full Text] [Related]
13. Association of
Yamamoto M; Watanabe M; Inoue N; Watanabe A; Ozaki H; Ohsaki M; Hidaka Y; Iwatani Y
Immunol Invest; 2020 Feb; 49(1-2):106-119. PubMed ID: 31505972
[TBL] [Abstract][Full Text] [Related]
14. Associations of single nucleotide polymorphisms in precursor-microRNA (miR)-125a and the expression of mature miR-125a with the development and prognosis of autoimmune thyroid diseases.
Inoue Y; Watanabe M; Inoue N; Kagawa T; Shibutani S; Otsu H; Saeki M; Takuse Y; Hidaka Y; Iwatani Y
Clin Exp Immunol; 2014 Nov; 178(2):229-35. PubMed ID: 24990808
[TBL] [Abstract][Full Text] [Related]
15. Association between functional SIRT1 polymorphisms and the clinical characteristics of patients with autoimmune thyroid disease.
Sarumaru M; Watanabe M; Inoue N; Hisamoto Y; Morita E; Arakawa Y; Hidaka Y; Iwatani Y
Autoimmunity; 2016 Aug; 49(5):329-37. PubMed ID: 27245255
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in the TNFA and IL6 genes represent risk factors for autoimmune thyroid disease.
Durães C; Moreira CS; Alvelos I; Mendes A; Santos LR; Machado JC; Melo M; Esteves C; Neves C; Sobrinho-Simões M; Soares P
PLoS One; 2014; 9(8):e105492. PubMed ID: 25127106
[TBL] [Abstract][Full Text] [Related]
17.
Kawabata M; Inoue N; Watanabe M; Kobayashi A; Hidaka Y; Miyauchi A; Iwatani Y
Autoimmunity; 2021 Nov; 54(7):450-459. PubMed ID: 34494503
[TBL] [Abstract][Full Text] [Related]
18. Clock gene
Helvaci N; Oguz SH; Kabacam S; Karabulut E; Akbiyik F; Alikasifoglu M; Gurlek A
Chronobiol Int; 2019 Oct; 36(10):1343-1350. PubMed ID: 31328557
[TBL] [Abstract][Full Text] [Related]
19. The functional polymorphisms of VDR, GC and CYP2R1 are involved in the pathogenesis of autoimmune thyroid diseases.
Inoue N; Watanabe M; Ishido N; Katsumata Y; Kagawa T; Hidaka Y; Iwatani Y
Clin Exp Immunol; 2014 Nov; 178(2):262-9. PubMed ID: 25046415
[TBL] [Abstract][Full Text] [Related]
20. IL-10 -592A/C polymorphism is associated with severity of Hashimoto's disease.
Inoue N; Watanabe M; Wada M; Morita M; Hidaka Y; Iwatani Y
Cytokine; 2013 Oct; 64(1):370-4. PubMed ID: 23757290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
